Skip to main content
. 2017 Feb 9;18(2):77. doi: 10.3390/ijms18020077

Figure 11.

Figure 11

GP-17 protected HUVECs against Ox-LDL-induced apoptosis by decreasing the ratio of Bax to Bcl-2 and controlling cleaved caspase-3 activation. (A) The expression of cleaved caspase-3 was analyzed by immunofluorescence assays; (B,C) The expression of apoptosis-inducing proteins mediated by GP-17 in Ox-LDL-induced HUVECs was abolished by pretreatment with ICI182780 or LY294002; (D) The protective effect of GP-17 against LDH release induced by Ox-LDL in HUVECs. The values are expressed as the mean ± S.E.M. from three independent experiments. ## p < 0.01; ### p < 0.001 vs. Control; ** p < 0.01; *** p < 0.001 vs. Ox-LDL; & p < 0.05; && p < 0.01; &&& p < 0.001 vs. GP-17 + Ox-LDL.